Just sharing some knowledge I gained recently.
Post# of 9122
Posted On: 10/01/2014 4:53:19 AM
Just sharing some knowledge I gained recently.
A friend who is an expert in the field informed me that more than half of all petri plates used to grow bacteria are used for the purpose of colony counting often with little regard to the specific identity of the bacteria. There is a threshold count that if not reached (over a specific period of time), the sampled product is allowed to continue through the manufacturing process. Quite a huge market segment that will benefit greatly by the Company's BNP product once adopted.
Follow links for more info:
http://en.wikipedia.org/wiki/Cell_counting
http://en.wikipedia.org/wiki/Colony-forming_unit
I found the sections "The need for cell counting" and "Plating and CFU counting" in the first link informative.
In a related topic, we know that Battelle researchers did the paper on BNP and TB wherein they proved the Company's claims of their BNP product. The recent writeup by UNITAID as well as the LinkedIn connections to Senior level people at WHO and Battelle is proof, imo, that things are moving along with the WHO and that good things will follow in 2015 after the field testing. This line from the recent PR (bold is by me) is indicative of my sentiment as well:
"The Company anticipates having their BNP technology included in TB studies in Africa and Australia in 2015"
The BARDA and ASPR parts of the PR were also pleasing. I may be reading too much into the wording, but "...meeting with BARDA Program Representatives and ASPR Contracting Officers ..." leads me to believe this may not be their first time meeting and that a deal is in the works.
A friend who is an expert in the field informed me that more than half of all petri plates used to grow bacteria are used for the purpose of colony counting often with little regard to the specific identity of the bacteria. There is a threshold count that if not reached (over a specific period of time), the sampled product is allowed to continue through the manufacturing process. Quite a huge market segment that will benefit greatly by the Company's BNP product once adopted.
Follow links for more info:
http://en.wikipedia.org/wiki/Cell_counting
http://en.wikipedia.org/wiki/Colony-forming_unit
I found the sections "The need for cell counting" and "Plating and CFU counting" in the first link informative.
In a related topic, we know that Battelle researchers did the paper on BNP and TB wherein they proved the Company's claims of their BNP product. The recent writeup by UNITAID as well as the LinkedIn connections to Senior level people at WHO and Battelle is proof, imo, that things are moving along with the WHO and that good things will follow in 2015 after the field testing. This line from the recent PR (bold is by me) is indicative of my sentiment as well:
"The Company anticipates having their BNP technology included in TB studies in Africa and Australia in 2015"
The BARDA and ASPR parts of the PR were also pleasing. I may be reading too much into the wording, but "...meeting with BARDA Program Representatives and ASPR Contracting Officers ..." leads me to believe this may not be their first time meeting and that a deal is in the works.
(0)
(0)Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼